Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

Pierce names new lab director and new president

The John B. Pierce Laboratory, a nonprofit, independent research institute affiliated with Yale University, recently named a new laboratory director and the first female president...

| By Kelley Gipson

Enko partners with Bayer on crop protection

Enko has announced details on its partnership with Bayer to develop diverse chemistries for crop protection. Applying drug discovery approaches from pharma to crop protection...

| By Kelley Gipson

Branford-based IsoPlexis considers IPO

Branford-based medical technology company IsoPlexis is looking to go public. Founded by Yale students in 2013, the company has developed technology that can help doctors develop...

| By Kelley Gipson

Thetis pancreatic cancer treatment is ‘orphan drug’

The FDA has designated Thetis Pharmaceuticals’ experimental treatment for pancreatic cancer an “orphan drug,” a label that makes the company eligible for tax credits and other...

| By Kelley Gipson

Alexion now officially part of AstraZeneca

New Haven-born Alexion Pharmaceuticals, whose blockbuster blood-disorder drug Soliris made it one of the Elm City’s biggest biotech success stories a decade ago, is now...

| By Kelley Gipson

InveniAI in collaboration with PRISM BioLab

InveniAI® has completed a milestone in its collaboration with PRISM BioLab. The milestone marks completion of the identification and validation of a small molecule drug candidate...

| By Kelley Gipson

Yale seen as growth engine for New Haven

Lauren Zucker is Yale University’s associate vice president for New Haven Affairs and University Properties. New Haven BIZ recently spoke with Zucker about Yale’s efforts to drive...

| By Kelley Gipson

Stamford’s Sema4 going public

Stamford health intelligence company Sema4 has completed its business combination with CM Life Sciences, paving the way for the combined company – Sema4 Holdings Corp....

| By Kelley Gipson

Biorez wins major award for BioBrace Implant

Biorez reports that its proprietary, and recently FDA-cleared BioBrace Implant, received the AOSSM ACE Award for ‘Accelerating the Cutting Edge.’ The award was given at...